BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37522227)

  • 1. Treatment of oromandibular dystonia with botulinum toxin A improves apnea in a teenager with quadriplegic cerebral palsy: A case report.
    Roberts J; Tenaglia A; Bellissimo E; Kim H
    J Pediatr Rehabil Med; 2024; 17(1):125-129. PubMed ID: 37522227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy.
    Reyes FI; Shoval HA; Tenaglia A; Kim H
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstructive sleep apnea due to oromandibular dystonia and treated with botulinum toxin.
    Hsu N; Hsieh C; Thomas A; Chang M
    J Clin Sleep Med; 2020 Jul; 16(7):1209-1212. PubMed ID: 32248896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oromandibular Dystonia Causing Recurrent Mandibular Open Lock in Two Adolescents Managed with Botulinum Toxin.
    Perez CV; Okeson J
    J Dent Child (Chic); 2019 Jan; 86(1):47-52. PubMed ID: 30992101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.
    Yoshida K
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin.
    Bakke M; Baram S; Dalager T; Biernat HB; Møller E
    J Oral Rehabil; 2019 May; 46(5):441-449. PubMed ID: 30664806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy.
    Blaszczyk I; Foumani NP; Ljungberg C; Wiberg M
    Toxins (Basel); 2015 Nov; 7(11):4645-54. PubMed ID: 26561833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for botulinum toxin in back pain treatment in adults with cerebral palsy: report of a case.
    Gallien P; Nicolas B; Petrilli S; Kerdoncuff V; Lassalles A; Le Tallec H; Durufle A
    Joint Bone Spine; 2004 Jan; 71(1):76-8. PubMed ID: 14769528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of sleep apnea in a patient with cerebral palsy.
    McCarty SF; Gaebler-Spira D; Harvey RL
    Am J Phys Med Rehabil; 2001 Jul; 80(7):540-2. PubMed ID: 11421524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
    Yoshida K
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report.
    Vazquez-Delgado E; Okeson JP
    Cranio; 2004 Oct; 22(4):325-9. PubMed ID: 15532318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of oromandibular dystonia with botulinum A toxin: a series of cases.
    Teemul TA; Patel R; Kanatas A; Carter LM
    Br J Oral Maxillofac Surg; 2016 Dec; 54(10):1080-1084. PubMed ID: 27776922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.